Last update :
24/05/2022
Stability and compatibility of drugs
Welcome in Stabilis. If you wish to receive the quarterly newsletter, indicate your email address. Sign up

If you have any questions or comments, please contact : infostab@stabilis.org
Database  
References : 2704
Compounds : 836
Pharmacological Class : 46
Stability of solutions : 6111
Stability in mixtures : 1199
Compatibility : 12068
Trade Name : 4605
News - Compounds  
Various Capsule Fludrocortisone acetate 05/05/2022
Antidementia Oral solution Pimavanserin 05/05/2022
Anticancer drug Oral solution Imatinib 03/05/2022
Anticancer drug Ointments Erlotinib 03/05/2022
Antifungal Ointments Voriconazole 03/05/2022
Electrolyte Injection Magnesium chloride 14/03/2022
Immunosuppressant Injection Adalimumab 06/03/2022
Hormone Ointments Gestrinone 04/03/2022
Anti-inflammatory Ointments Nimesulide 04/03/2022
Anti-inflammatory Ointments Piroxicam 04/03/2022
Various Oral solution Quetiapine fumarate 24/02/2022
Anti-inflammatory Paper bag Hydrocortisone 24/02/2022
Antihypertensive Paper bag Clonidine hydrochloride 24/02/2022
Analgesic Ointments Morphine hydrochloride 24/02/2022
Antibiotic Oral solution Co-trimoxazole 07/12/2021
Anticancer drug Injection Isatuximab 01/12/2021
Various Oral solution Tizanidine hydrochloride 29/11/2021
Anxiolytic Suppository Diazepam 29/11/2021
General anesthetic Oral solution Ketamine hydrochloride 15/10/2021
Anticancer drug Injection Pemetrexed disodium hemipentahydrate 27/09/2021
News - References  
Date of Entry
4686 Pertuzumab (Perjeta®) - Summary of Product Characteristics. Roche Products Ltd. 24/05/2022
4673 Physicochemical Stability of a Novel Tacrolimus Ophtalmic Formulation for the Treatment of Ophtalmic Inflammatory Diseases. Pharmaceutics 16/03/2022
4670 Stability and Formulation of Erlotinib in Skin Creams. Molecules 09/03/2022
4671 Voriconazole topical cream formulation: evidence for stability and antifungal activity. Int J Antimicrob Agents 09/03/2022
4665 LEMTRADA 12 mg concentrate for solution for infusion - Summary of Product Characteristics. Updated 24-Sep-2021 Sanofi Aventis 15/02/2022
4661 Stability of a high-concentrated aqueous solution of idarubicin stored in a polypropylene syringe for transarterial chemoembolization J Pharm Biomed Anal 05/02/2022
4655 Physical compatibility of Normosol-R with critical care medications used in patients with COVID-19 during simulated Y-site administration. Am J Health-Syst Pharm 25/01/2022
4653 Development of a sterile morphine hydrogel for the local treatment of painful skin ulcers. EJHP 24/01/2022
4654 Compatibilité visuelle du Vyxeos® lors d'administration en Y avec une sélection de médicaments injectables. Communication personnelle 24/01/2022
4652 Nivolumab (Opdivo®) - Summary of Product Characteristics Bristol Myers Squibb Pharmaceuticals 22/01/2022
4651 Physical compatibility of alprostadil with selected drugs commonly used in the neonatal intensive care units. Eur J Pedia 18/01/2022
4650 Ceftobiprole (Zevtera 500 mg powder for concentrate for solution for infusion.) Summary of Product Characteristics, Advanz Pharma updated 4 aug 2021. Advanz Pharma 12/01/2022
4649 Extended stability of the trastuzumab biosimilar ABP 980 (KANJINTI™) in polyolefin bags and elastomeric devices. GaBI Journal 29/12/2021
4648 Stability evaluation of compounded clonidine hydrochloride oral liquids based on a solidphase extraction HPLC-UV method. PlosOne 16/12/2021
4646 Stability Studies of Fludrocortisone Acetate Capsules and Fludrocortisone Acetate Titrated Powders (Powder Triturates). Int J Pharm Compound 24/11/2021
4645 Assessment of ceftolozane/tazobactam stability in elastomeric devices and suitability for continuous infusion via outpatient parenteral antimicrobial therapy. JAC Antimicrob Resist 17/11/2021
4643 Evaluation of 30-day stability of morphine hydrochloride and clonidine at high and low concentrations in polypropylene syringes. EJHP 15/11/2021
4640 Stability of Ampicillin in Normal Saline Following Refrigerated Storage and 24-Hour Pump Recirculation. Hosp Pharm 08/11/2021
4641 Stability of high concentrated triple intrathecal therapy for pediatrics and mitigation strategies. Eur J Pharm Sci 08/11/2021
4638 Stability of Extemporaneously Compounded Suspensions of Trimethoprim and Sulfamethoxazole in Amber Plastic Bottles and Amber Plastic Syringes. Can J Hosp Pharm 03/11/2021
4639 Stability of N-Acetylcysteine 60 mg/mL in Extemporaneously Compounded Injectable Solutions. Can J Hosp Pharm 03/11/2021
4636 Design and stability of pediatric oral formulation of imatinib J Oncol Pharm Practice 26/10/2021
4637 Evaluation of physicochemical and microbiological stability of liquid preparation from tizanidine hydrochloride tablets - a Hospital concern. Braz J Pharm Sci 26/10/2021
4635 Physicochemical stability of human insulin 1 I.U./mL infusion solution in 50 mL polypropylene syringes. Pharmaceutical Technology in Hospital Pharmacy 04/10/2021
4634 Stability studies of 16 Antibiotics for Continuous Infusion in Intensive Care Units and for Performing Outpatient Parenteral Antimicrobial Therapy. Antibiotics 30/09/2021
4630 Stability of clonidine hydrochloride in an oral powder form compounded for pediatric patients in Japan. J Pharm Health Care Sci 29/09/2021
4633 Physicochemical Stability and Compatibility Testing of Voriconazole in All-in-One Parenteral Nutrition Admixtures. Pharmaceutics 29/09/2021
4629 Pemetrexed Sandoz - Summary of Product Characteristics (SmPc) 27/09/2021
4628 Development and Validation of a New Storage Procedure to Extend the In-Use Stability of Azacitidine in Pharmaceutical Formulations. Pharmaceuticals 24/09/2021
4627 Evaluation of Physicochemical and Biological Stability of 36-Months-Aged SB5 (Adalimumab Biosimilar) for 4 Weeks at Room Temperature. Adv Ther 21/09/2021

  Mentions Légales